Link Pharmachem Limited

BSE: 524748
Link Pharmachem Limited - pharma in Baroda, Gujarat, India. FY 2026 financials and compliance.
CIN L24230GJ1984PLC007540 Incorporated 28 December 1984 ROC Ahmedabad HQ Baroda, Gujarat, India
Active Listed - BSE: 524748 Public Limited Company pharma
Data last updated
Revenue · FY 2026
₹27.43 Cr
▲ 7.86% YoY
EBITDA · FY 2026
₹1.64 Cr
▲ 420.64% YoY
Net profit · FY 2026
₹7.68 Lakh
▲ 107.48% YoY
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹4.44 Cr
Issued & subscribed
Open charges
₹19.22 Cr
Satisfied ₹20.51 Cr
Company age
42 yrs
Est. 1984
Employees · EPFO
84
Latest available

About Link Pharmachem Limited

Data last updated: 31 December 2025

Link Pharmachem Limited is a public limited company based in Baroda, Gujarat, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 28 December 1984, the company has been in operation for over 42 years.

Registered with ROC Ahmedabad under CIN L24230GJ1984PLC007540. Listed on BSE: 524748.

Capital: an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.44 Cr. Formerly known as Link Pharmachem Private Limited. It is led by directors including Rishikesh Thakur and Rachna Manav Ghai.

Last AGM: 09 September 2025. Financial statements filed for year ended 31 March 2025. Office: 162 G.I.D.C Estate Nandesari, Baroda, Gujarat, India – 393002.

As per the financials filed for FY 2025, the company reported a revenue of ₹25.62 Cr, a decline of 16% compared to the previous year.

The company has a workforce of approximately 84 employees as per the latest available data.

The company is associated with 1 brand - Link Pharma. As per MCA filings, the company has open charges of ₹19.22 Cr and satisfied charges of ₹20.51 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website linkpharmachem.co.in.

Company Details of Link Pharmachem Limited
CIN L24230GJ1984PLC007540
Registration Number 007540
Incorporation Date 28 December 1984
ROC Ahmedabad
Listing Status Listed (BSE: 524748)
Company Status Active
Date of Last AGM 09 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Rishikesh Thakur Managing Director Satish Ganpatrao Thakur Whole-Time Director Rachna Manav Ghai Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
    linkpharmachem.co.in
  • Social Media
    **************
  • Registered Address
    162 G.I.D.C Estate Nandesari, Baroda, Gujarat, India – 393002
  • Industry
    Pharma, Drug Formulation & Development
Company report
Link Pharmachem Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Link Pharmachem Limited report

Financials, compliance, directors, charges, ownership and filings for Link Pharmachem Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Link Pharmachem Limited

Link Pharmachem Limited operates one associated brand: Link Pharma. These brands represent Link Pharmachem Limited's diversified market presence and brand portfolio.

Brand Description Website
Link Pharma
Developing and manufacturing services for APIs and specialty chemicals linkpharmachem.co.in

Competitors & Alternatives of Link Pharmachem Limited

Brands and companies operating in the same space as Link Pharmachem Limited include Laurus Labs, Symbiotec, Beijing Biostar Technologies and 6 more.

Competitor Description Location Founded
Laurus Labs Laurus Labs Pharmaceutical and biotechnology company Hyderabad, India, India 2005
Symbiotec Symbiotec Non-sterile steroid hormone-based APIs and intermediates are manufactured. Indore, India, India 2002
Beijing Biostar Technologies Beijing Biostar Technologies APIs, intermediates, and biochemical reagents are developed and manufactured. Beijing, China, China 2002
Sterling Pharma Solutions Sterling Pharma Solutions Contract development, manufacturing, and analytical services for APIs are offered. Dudley, United Kingdom, United Kingdom 2016
Provepharm Life Solutions Provepharm Life Solutions APIs and drug products are developed and valorized in pharmaceuticals. Marseille, France, France 1998
Hikal Hikal APIs and intermediates are produced via custom synthesis and research. Mumbai, India, India 1988
Snapdragon Chemistry Snapdragon Chemistry Drug discovery and development service provider Cambridge, United States, United States 2014
SeQuent SeQuent APIs are developed and manufactured for therapeutic areas. Bengaluru, India, India 2002
Jubilant Pharma Jubilant Pharma Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. Noida, India, India 1978

Business Activity of Link Pharmachem Limited

Link Pharmachem Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products *********

Auditor Details of Link Pharmachem Limited

Link Pharmachem Limited is audited by CNK & Associates LLP (ICAI peer reviewed, certificate valid till 2027-07-31) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
CNK & Associates LLP (ICAI peer reviewed, certificate valid till 2027-07-31) FY 2026 Declaration of unmodified opinion

Board of Directors of Link Pharmachem Limited

Link Pharmachem Limited is currently managed by 7 directors, with 14 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Rishikesh Thakur
Also directs: Aarohan Chemicals Private Limited
Managing Director 24 Jun 2020 6 Years 0 Months Current
Rachna Manav Ghai
Also directs: Mindset Llp
Director 14 Sep 2020 5 Years 9 Months Current
Rangoli Saurav Gada
Also directs: Shine Pharmaceuticals Limited, Medicap Healthcare Limited
Director 09 Aug 2024 1 Years 10 Months Current
Satish Ganpatrao Thakur Whole-Time Director 28 Dec 1984 41 Years 6 Months Current
Rohit Jitendraprasad Shah Director 09 Aug 2024 1 Years 10 Months Current
Showing 6 of 7 current directors. View all directors

Financials of Link Pharmachem Limited FY 2026 filings available

Link Pharmachem Limited reported revenue of ₹27.43 Cr (up 7.86% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue · FY 2026
₹27.43 Cr ▲ 7.86%
Profit · FY 2026
₹7.68 Lakh ▲ 107.48%
EBITDA · FY 2026
₹1.64 Cr ▲ 420.64%
Revenue₹ Cr · Standalone0204060FY 2019: ₹25 Cr24.5FY 2019FY 2020: ₹25 Cr · +4% YoY25.5+4%FY 2020FY 2021: ₹35 Cr · +36.7% YoY34.8+36.7%FY 2021FY 2022: ₹54 Cr · +53.9% YoY53.6+53.9%FY 2022FY 2023: ₹39 Cr · -27.6% YoY38.8-27.6%FY 2023FY 2024: ₹30 Cr · -22.9% YoY29.9-22.9%FY 2024FY 2025: ₹25 Cr · -14.9% YoY25.4-14.9%FY 2025FY 2026: ₹27 Cr · +7.9% YoY27.4+7.9%FY 2026
Net Profit₹ Cr · Standalone-2-1012FY 2019: ₹1 Cr0.7FY 2019FY 2020: ₹1 Cr · +44.3% YoY0.9+44.3%FY 2020FY 2021: ₹1 Cr · +14.2% YoY1.1+14.2%FY 2021FY 2022: ₹2 Cr · +73.4% YoY1.9+73.4%FY 2022FY 2023: ₹1 Cr · -65.2% YoY0.7-65.2%FY 2023FY 2024: ₹1 Cr (loss) · -308.3% YoY-1.4FY 2024FY 2025: ₹1 Cr (loss) · +24.6% YoY-1FY 2025FY 2026: ₹0 Cr · +107.5% YoY0.1+107.5%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year0510Q1'25: ₹9 Cr8.8Q1'25Q2'25: ₹5 Cr4.8Q2'25Q3'25: ₹5 Cr5.3Q3'25Q4'25: ₹6 Cr6.4Q4'25Q1'26: ₹8 Cr · -11.7% YoY7.8-11.7%Q1'26Q2'26: ₹6 Cr · +31.2% YoY6.3+31.2%Q2'26Q3'26: ₹7 Cr · +26.1% YoY6.7+26.1%Q3'26Q4'26: ₹7 Cr · +2.2% YoY6.6+2.2%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Revenue from Operations ₹27.43 Cr ₹25.43 Cr ₹29.9 Cr ₹38.76 Cr ₹53.56 Cr ₹34.81 Cr ₹25.47 Cr ₹24.5 Cr
Other Income ₹20.34 Lakh ₹18.65 Lakh ₹64.03 Lakh -₹14.73 Lakh ₹46.44 Lakh ₹2.15 Lakh ₹10.19 Lakh ₹19.29 Lakh
Total Income ₹27.63 Cr ₹25.62 Cr ₹30.54 Cr ₹38.61 Cr ₹54.03 Cr ₹34.83 Cr ₹25.57 Cr ₹24.69 Cr
Cost of Materials Consumed ₹10.62 Cr ₹11.22 Cr ₹14.37 Cr ₹26.41 Cr ₹37.89 Cr ₹17.93 Cr ₹8.9 Cr ₹11.87 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹13.68 Lakh ₹1.33 Cr ₹2.31 Cr -₹5.04 Cr -₹1.45 Cr -₹15.59 Lakh ₹1.01 Cr -₹54.77 Lakh
Employee Benefit Expense ₹6.09 Cr ₹5.39 Cr ₹5.52 Cr ₹5.69 Cr ₹5.77 Cr ₹5.63 Cr ₹4.99 Cr ₹4.72 Cr
Finance Costs ₹52.98 Lakh ₹77.55 Lakh ₹87.2 Lakh ₹76.1 Lakh ₹45.12 Lakh ₹44.04 Lakh ₹36.12 Lakh ₹38.55 Lakh
Depreciation & Amortisation ₹97.99 Lakh ₹94.29 Lakh ₹1.03 Cr ₹92.28 Lakh ₹92.78 Lakh ₹87.4 Lakh ₹92.79 Lakh ₹89.49 Lakh
Other Expenses ₹9.15 Cr ₹7.37 Cr ₹8.35 Cr ₹8.99 Cr ₹7.82 Cr ₹8.44 Cr ₹7.94 Cr ₹6.44 Cr
Total Expenses ₹27.5 Cr ₹27.02 Cr ₹32.45 Cr ₹37.72 Cr ₹51.4 Cr ₹33.16 Cr ₹24.13 Cr ₹23.76 Cr
Profit Before Exceptional Items & Tax ₹13.5 Lakh -₹1.4 Cr -₹1.92 Cr ₹88.63 Lakh ₹2.62 Cr ₹1.68 Cr ₹1.44 Cr ₹93.01 Lakh
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹13.5 Lakh -₹1.4 Cr -₹1.92 Cr ₹88.63 Lakh ₹2.62 Cr ₹1.68 Cr ₹1.44 Cr ₹93.01 Lakh
Total Tax Expense ₹5.82 Lakh -₹37.52 Lakh -₹55.28 Lakh ₹23.21 Lakh ₹73.99 Lakh ₹59.36 Lakh ₹49.14 Lakh ₹27.19 Lakh
Net Profit ₹7.68 Lakh -₹1.03 Cr -₹1.36 Cr ₹65.42 Lakh ₹1.88 Cr ₹1.08 Cr ₹94.98 Lakh ₹65.82 Lakh
Other Comprehensive Income ₹5.04 Lakh -₹1.93 Lakh ₹3.25 Lakh -₹9.01 Lakh ₹3.24 Lakh ₹4.27 Lakh ₹10.17 Lakh ₹0
Total Comprehensive Income ₹12.72 Lakh -₹1.05 Cr -₹1.33 Cr ₹56.41 Lakh ₹1.91 Cr ₹1.13 Cr ₹1.05 Cr ₹65.82 Lakh
EBITDA (computed) ₹1.64 Cr ₹31.59 Lakh -₹95,000 ₹2.57 Cr ₹4 Cr ₹2.99 Cr ₹2.73 Cr ₹2.21 Cr
Basic EPS ₹0.17 ₹-2.31 ₹-3.07 ₹1.47 ₹4.24 ₹2.44 ₹2.14 ₹1.48
Diluted EPS ₹0.17 ₹-2.31 ₹-3.07 ₹1.47 ₹4.24 ₹2.44 ₹2.14 ₹1.48
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Total Assets ₹24.96 Cr ₹23.29 Cr ₹25.95 Cr ₹32.46 Cr ₹28.96 Cr ₹26.2 Cr ₹18.97 Cr ₹18 Cr
Non-current Assets ₹13.62 Cr ₹12.13 Cr ₹14.42 Cr ₹14.91 Cr ₹15.39 Cr ₹10.92 Cr ₹9.88 Cr ₹10.82 Cr
Current Assets ₹11.34 Cr ₹11.16 Cr ₹11.53 Cr ₹17.55 Cr ₹13.58 Cr ₹15.28 Cr ₹9.08 Cr ₹7.18 Cr
Property, Plant & Equipment ₹10.38 Cr ₹9.28 Cr ₹9.94 Cr ₹9 Cr ₹8.79 Cr ₹8.71 Cr ₹8.81 Cr ₹9.14 Cr
Inventories ₹5.02 Cr ₹5.74 Cr ₹6.21 Cr ₹12.25 Cr ₹4.76 Cr ₹2.5 Cr ₹1.63 Cr ₹2.87 Cr
Trade Receivables ₹5.28 Cr ₹5.02 Cr ₹5.15 Cr ₹3.63 Cr ₹5.37 Cr ₹5.55 Cr ₹4.99 Cr ₹3.04 Cr
Cash & Equivalents ₹54.59 Lakh ₹6.45 Lakh ₹6.42 Lakh ₹9.39 Lakh ₹26.79 Lakh ₹4.22 Cr ₹1.87 Cr ₹2.47 Lakh
Equity (Net Worth) ₹12.79 Cr ₹12.66 Cr ₹13.71 Cr ₹15.04 Cr ₹14.47 Cr ₹12.56 Cr ₹11.43 Cr ₹10.38 Cr
Equity Share Capital ₹4.44 Cr ₹4.44 Cr ₹4.44 Cr ₹4.44 Cr ₹4.44 Cr ₹4.44 Cr ₹4.44 Cr ₹4.44 Cr
Borrowings (Non-current) ₹69.51 Lakh ₹41.74 Lakh ₹1.06 Cr ₹1.98 Cr ₹2.9 Cr ₹3.16 Cr ₹3.17 Cr ₹1.71 Cr
Borrowings (Current) ₹6.61 Cr ₹5.37 Cr ₹8.16 Cr ₹6.78 Cr ₹3.49 Cr ₹0 ₹0 ₹65.75 Lakh
Total Debt (computed) ₹7.3 Cr ₹5.78 Cr ₹9.22 Cr ₹8.76 Cr ₹6.39 Cr ₹3.16 Cr ₹3.17 Cr ₹2.36 Cr
Current Liabilities ₹11.24 Cr ₹10.05 Cr ₹11.01 Cr ₹14.51 Cr ₹10.61 Cr ₹9.44 Cr ₹3.45 Cr ₹4.88 Cr
Total Liabilities ₹12.17 Cr ₹10.63 Cr ₹12.24 Cr ₹17.42 Cr ₹14.49 Cr ₹13.64 Cr ₹7.53 Cr ₹7.62 Cr
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹2.15 Cr ₹2.69 Cr -₹2.8 Lakh -₹1.71 Cr -₹1.25 Cr
Investing Cash Flow -₹2.66 Cr ₹1.53 Cr ₹40.52 Lakh -₹7.5 Lakh -₹4.98 Cr
Financing Cash Flow ₹99.2 Lakh -₹4.21 Cr -₹40.69 Lakh ₹1.61 Cr ₹2.27 Cr
Capital Expenditure ₹2.1 Cr ₹25.72 Lakh ₹95.03 Lakh ₹89.29 Lakh ₹1.16 Cr
Free Cash Flow (computed) ₹4.65 Lakh ₹2.43 Cr -₹97.83 Lakh -₹2.6 Cr -₹2.41 Cr
Dividends Paid ₹0 ₹0 ₹0 ₹0 ₹0
Net Change in Cash ₹48.13 Lakh ₹3,000 -₹2.97 Lakh -₹17.4 Lakh -₹3.95 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25
Revenue from Operations ₹6.59 Cr ₹6.73 Cr ₹6.29 Cr ₹7.81 Cr ₹6.45 Cr ₹5.34 Cr ₹4.8 Cr ₹8.85 Cr
Other Income ₹14.74 Lakh -₹20.1 Lakh ₹4.78 Lakh ₹20.92 Lakh ₹11.79 Lakh -₹56.16 Lakh ₹35.86 Lakh ₹27.16 Lakh
Total Income ₹6.74 Cr ₹6.53 Cr ₹6.34 Cr ₹8.02 Cr ₹6.56 Cr ₹4.78 Cr ₹5.16 Cr ₹9.12 Cr
Cost of Materials Consumed ₹2.11 Cr ₹3.24 Cr ₹2.57 Cr ₹2.7 Cr ₹1.32 Cr ₹2.29 Cr ₹2.61 Cr ₹5 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹79.95 Lakh -₹89.68 Lakh -₹38.07 Lakh ₹61.48 Lakh ₹1.95 Cr ₹1.09 Lakh -₹70.56 Lakh ₹7.63 Lakh
Employee Benefit Expense ₹1.45 Cr ₹1.69 Cr ₹1.41 Cr ₹1.53 Cr ₹1.34 Cr ₹1.33 Cr ₹1.42 Cr ₹1.31 Cr
Finance Costs ₹15.29 Lakh ₹14.42 Lakh ₹12.86 Lakh ₹10.4 Lakh ₹14.14 Lakh ₹20.53 Lakh ₹20.85 Lakh ₹22.03 Lakh
Depreciation & Amortisation ₹24.51 Lakh ₹24.8 Lakh ₹24.77 Lakh ₹23.91 Lakh ₹23.62 Lakh ₹23.54 Lakh ₹23.59 Lakh ₹23.54 Lakh
Other Expenses ₹2.47 Cr ₹2 Cr ₹2.35 Cr ₹2.33 Cr ₹2.07 Cr ₹1.6 Cr ₹1.78 Cr ₹1.92 Cr
Total Expenses ₹7.23 Cr ₹6.43 Cr ₹6.33 Cr ₹7.51 Cr ₹7.05 Cr ₹5.67 Cr ₹5.55 Cr ₹8.76 Cr
Profit Before Exceptional Items & Tax -₹49 Lakh ₹10.32 Lakh ₹1.23 Lakh ₹50.97 Lakh -₹48.27 Lakh -₹89.09 Lakh -₹38.91 Lakh ₹36.03 Lakh
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax -₹49 Lakh ₹10.32 Lakh ₹1.23 Lakh ₹50.97 Lakh -₹48.27 Lakh -₹89.09 Lakh -₹38.91 Lakh ₹36.03 Lakh
Total Tax Expense -₹8.14 Lakh ₹3.5 Lakh -₹33,000 ₹10.78 Lakh -₹13.25 Lakh -₹22.38 Lakh -₹8.28 Lakh ₹6.39 Lakh
Net Profit -₹40.86 Lakh ₹6.82 Lakh ₹1.56 Lakh ₹40.19 Lakh -₹35.02 Lakh -₹66.71 Lakh -₹30.63 Lakh ₹29.64 Lakh
Other Comprehensive Income ₹6.13 Lakh -₹39,000 -₹55,000 -₹15,000 -₹4.25 Lakh ₹60,000 ₹85,000 ₹86,000
Total Comprehensive Income -₹34.73 Lakh ₹6.43 Lakh ₹1.01 Lakh ₹40.04 Lakh -₹39.27 Lakh -₹66.11 Lakh -₹29.78 Lakh ₹30.5 Lakh
EBITDA (computed) -₹9.2 Lakh ₹49.54 Lakh ₹38.86 Lakh ₹85.28 Lakh -₹10.51 Lakh -₹45.02 Lakh ₹5.53 Lakh ₹81.6 Lakh
Basic EPS ₹-0.92 ₹0.15 ₹0.03 ₹0.91 ₹-0.79 ₹-1.50 ₹-0.69 ₹0.67
Diluted EPS ₹-0.92 ₹0.15 ₹0.03 ₹0.91 ₹-0.79 ₹-1.50 ₹-0.69 ₹0.67
Latest 8 quarters shown.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Link Pharmachem Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Link Pharmachem Limited

As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 52.40%, domestic institutional investors hold 0.02%, retail and other public shareholders hold 47.58% of Link Pharmachem Limited. The company had 6,020 shareholders on record.

Promoters: 52.40%DII (Domestic Institutional): 0.02%Retail & Others: 47.58%
Mar 2026
QUARTER
52.40% Promoters
0.02% DII (Domestic Institutional)
47.58% Retail & Others
Promoter holding - history
Now 52.40% · Mar 2026High 52.40% · Mar 2026Low 51.49% · Jun 2023
50%51%52%53%54%Jun 2023Dec 2023Jun 2024Dec 2024Jun 2025Dec 2025Jun 2023: 51.49%Sep 2023: 51.49%Dec 2023: 51.49%Mar 2024: 51.49%Jun 2024: 51.49%Sep 2024: 51.49%Dec 2024: 51.49%Mar 2025: 51.49%Jun 2025: 51.49%Sep 2025: 51.49%Dec 2025: 51.49%Mar 2026: 52.40%51.49%52.40%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters52.40%51.49%51.49%51.49%51.49%51.49%
Public47.60%48.51%48.51%48.51%48.51%48.51%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024
Promoters52.40%51.49%51.49%
Public47.60%48.51%48.51%
Promoter change (YoY, %pts)+0.91+0.00-

Charges & Borrowings of Link Pharmachem Limited

Open charges
₹19.22 Cr
Satisfied charges
₹20.51 Cr
Breakdown by lending institutions
Bank of India₹19.22 Cr
Latest charge details
DateLenderAmountStatus
24 Nov 2006 Bank of India ₹9.61 Cr Open
07 Oct 2006 Bank of India ₹9.61 Cr Open
16 Jul 2016 Others ₹22.71 Lakh Satisfied
16 Dec 2003 State Bank of India ₹2.23 Cr Satisfied
28 Jul 2000 State Bank of India ₹3 Cr Satisfied

Total charge records: 17 View all charges

Employees and EPFO Compliance at Link Pharmachem Limited

Link Pharmachem Limited has a workforce of 84 employees as of Dec 31, 2025.

Employee count
84
Active EPFO establishments
1
Employee growth
-1.18%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Link Pharmachem Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Link Pharmachem Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Link Pharmachem Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Link Pharmachem Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Link Pharmachem Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Link Pharmachem Limited

MSME Payment Delays by Link Pharmachem Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Link Pharmachem Limited

Subsidiaries & Group Companies of Link Pharmachem Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Link Pharmachem Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Link Pharmachem Limited

MCA Filings & Documents of Link Pharmachem Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Link Pharmachem Limited

Charges
16 Sep 2025
A charge with Bank Of India of Rs. 9.61 Cr registered on 24 Nov 2006 with Charge ID 10027597 was modified on 16 Sep 2025.
Activity
09 Sep 2025
Link Pharmachem Limited last Annual general meeting of members was held on 09 Sep 2025 as per latest MCA records.
Charges
18 Jul 2025
A charge with Bank Of India of Rs. 9.61 Cr registered on 07 Oct 2006 with Charge ID 10022267 was modified on 18 Jul 2025.
Activity
31 Mar 2025
Link Pharmachem Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Directors
09 Aug 2024
Rangoli Saurav Gada was appointed as a Director on 09 Aug 2024 & has been associated with this company since 1 year 10 months.
Directors
09 Aug 2024
Rohit Jitendraprasad Shah was appointed as a Director on 09 Aug 2024 & has been associated with this company since 1 year 10 months.

Frequently Asked Questions about Link Pharmachem Limited

Link Pharmachem Limited is an active public limited company in the pharma sector based in Baroda, Gujarat, India. It was incorporated on 28 December 1984 (42+ years old) and is registered under CIN L24230GJ1984PLC007540. Listed on BSE: 524748. The company has 84 employees.

Link Pharmachem Limited reported revenue of ₹25.62 Cr for FY 2025 (down 16.00% YoY).

The current directors of Link Pharmachem Limited are:

The primary industry of Link Pharmachem Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Yes. Link Pharmachem Limited is listed on BSE with code 524748.

Link Pharmachem Limited can be reached at the registered office: 162 G.I.D.C Estate Nandesari, Baroda, Gujarat, India – 393002, or through the website linkpharmachem.co.in.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available